ReviewCancer discovery2017

Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax.

Joel D Leverson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.